tirzepatida glp 1 y GLP-1: qué son, cuándo usarlos y qué diferencias hay Mounjaro tirzepatida GLP-1 agonista del

Int J Mol Med 41(5):29772985

thats why Im here

The cause of the adverse effects related to the drugs utilized in the management of diabetes is multifactorial, including genetic predisposition, glycemic control, diabetic gastroparesis diagnosis, and dose and pharmacokinetics of the drug employed

This is because there is not enough safety data to know whether taking a GLP-1 medicine can cause harm to the baby. That means even if youre trying to lose weight after birth, GLP-1s are not considered safe while nursing

AOD 9604 is the right peptide for someone who is already metabolically functional, who wants to address specific fat compartments, and who cannot tolerate or is not a clinical candidate for GLP-1 therapy